Formononetin as anti-invasive agent for breast cancer, could inhibits migration and invasion of breast cancer cells by suppressing MMP-2 and MMP-9 through PI3K/AKT signaling pathways [78]. This evidence concerns the gene AKT1 and breast carcinoma.